全文获取类型
收费全文 | 3980篇 |
免费 | 226篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 41篇 |
儿科学 | 52篇 |
妇产科学 | 30篇 |
基础医学 | 595篇 |
口腔科学 | 49篇 |
临床医学 | 345篇 |
内科学 | 896篇 |
皮肤病学 | 55篇 |
神经病学 | 601篇 |
特种医学 | 195篇 |
外科学 | 610篇 |
综合类 | 24篇 |
预防医学 | 174篇 |
眼科学 | 102篇 |
药学 | 260篇 |
中国医学 | 11篇 |
肿瘤学 | 182篇 |
出版年
2023年 | 27篇 |
2022年 | 67篇 |
2021年 | 100篇 |
2020年 | 60篇 |
2019年 | 71篇 |
2018年 | 77篇 |
2017年 | 60篇 |
2016年 | 92篇 |
2015年 | 107篇 |
2014年 | 145篇 |
2013年 | 189篇 |
2012年 | 247篇 |
2011年 | 258篇 |
2010年 | 156篇 |
2009年 | 153篇 |
2008年 | 228篇 |
2007年 | 279篇 |
2006年 | 236篇 |
2005年 | 253篇 |
2004年 | 211篇 |
2003年 | 210篇 |
2002年 | 200篇 |
2001年 | 48篇 |
2000年 | 42篇 |
1999年 | 39篇 |
1998年 | 54篇 |
1997年 | 43篇 |
1996年 | 40篇 |
1995年 | 28篇 |
1994年 | 29篇 |
1993年 | 18篇 |
1992年 | 19篇 |
1991年 | 20篇 |
1990年 | 22篇 |
1989年 | 17篇 |
1988年 | 26篇 |
1987年 | 28篇 |
1986年 | 20篇 |
1985年 | 28篇 |
1984年 | 15篇 |
1983年 | 11篇 |
1982年 | 14篇 |
1981年 | 17篇 |
1980年 | 11篇 |
1979年 | 10篇 |
1977年 | 10篇 |
1975年 | 9篇 |
1974年 | 10篇 |
1972年 | 14篇 |
1938年 | 8篇 |
排序方式: 共有4222条查询结果,搜索用时 15 毫秒
71.
72.
73.
Weidner Kathrin Behnes Michael Schupp Tobias Hoppner Jorge Ansari Uzair Mueller Julian Lindner Simon Borggrefe Martin Kim Seung-hyun Huseyinov Aydin Ellguth Dominik Akin Muharrem Meininghaus Dirk Große Bertsch Thomas Taton Gabriel Bollow Armin Reichelt Thomas Engelke Niko Reiser Linda Akin Ibrahim 《Journal of interventional cardiac electrophysiology》2022,63(1):13-20
Journal of Interventional Cardiac Electrophysiology - The study sought to assess the prognostic impact of chronic kidney disease (CKD) in patients with electrical storm (ES). ES represents a... 相似文献
74.
Yap Sing-Chien Anic Ante Breskovic Toni Haas Annika Bhagwandien Rohit E. Jurisic Zrinka Szili-Torok Tamas Luik Armin 《Journal of interventional cardiac electrophysiology》2022,64(3):565-565
Journal of Interventional Cardiac Electrophysiology - 相似文献
75.
76.
Richter CM Godes M Wagner C Maser-Gluth C Herzfeld S Dorn M Priem F Slowinski T Bauer C Schneider W Neumayer HH Kurtz A Hocher B 《Journal of hypertension》2004,22(1):191-198
BACKGROUND: It has been shown that the macula densa participates in the regulation of increased renin expression in two-kidney one-clip (2K1C) renovascular hypertension. Prostaglandins might be one of the mediators of macula densa function, because the cyclooxygenase-2 (COX-2), one of the rate-limiting enzymes of the prostaglandin pathway, is upregulated in 2K1C renovascular hypertensive rats. We tested the effect of chronic COX-2 inhibition on blood pressure, urinary aldosterone excretion and kidney morphology, as well as kidney function. METHODS: Four groups were established: two groups of 2K1C renovascular hypertensive rats treated with the specific COX-2 inhibitor Celecoxib (cele) (15 mg/kg per day) or placebo immediately after operation, and two sham-operated control groups fed with Celecoxib or placebo. RESULTS: Long-term COX-2 inhibition in 2K1C renovascular hypertensive rats did not alter blood pressure at any point of time. Urinary aldosterone excretion was elevated by clipping the renal artery (2K1C, 8.1 +/- 1.9, versus controls, 3.6 +/- 0.5 ng/24 h; P = 0.05) but was not influenced by treatment with Celecoxib. Also, Celecoxib treatment did not alter glomerular filtration rate (GFR), serum sodium, serum creatinine, serum urea or proteinuria in 2K1C renovascular hypertensive rats. Interstitial fibrosis of the left clipped kidney was markedly reduced (2K1C, 6.19 +/- 0.83% versus 2K1C + cele 3.00 +/- 0.68% of total area; P = 0.012), whereas the interstitial fibrosis of the non-clipped kidney or the glomerulosclerosis of both kidneys were not affected by Celecoxib treatment. CONCLUSIONS: Celecoxib reduces the interstitial fibrosis of the clipped kidney. Blood pressure, urinary aldosterone excretion or whole kidney function were not affected in renal hypertensive rats. 相似文献
77.
78.
Sujata Vaidyanathan Michael Bartlett Hans Armin Dieterich Ching‐Ming Yeh Ana Antunes Dan Howard William P. Dole 《Cardiovascular therapeutics》2008,26(4):238-246
This study investigated the pharmacokinetics, safety, and tolerability of aliskiren administered alone or in combination with either the loop diuretic furosemide or an oral extended‐release formulation of isosorbide‐5‐mononitrate (ISMN). In separate studies, 22 healthy subjects (ages 18–45 years) received either ISMN 40 mg or furosemide 20 mg once‐daily for 3 days followed by a 3‐day washout. Subjects then received aliskiren 300 mg once‐daily for 7 days followed by combination therapy for 3 days. Pharmacokinetic assessments were taken at regular intervals over 24 h after dosing on the last day of each treatment period. At steady state, aliskiren AUCτ was decreased by 7% (geometric mean ratio [90% CI], 0.93 [0.84, 1.04]), and Cmax by 20% (0.80 [0.65, 0.97]) with furosemide coadministration compared with aliskiren administration alone. Aliskiren coadministration reduced furosemide AUCτ by 28% (0.72 [0.64, 0.81]) and Cmax by 49% (0.51 [0.39, 0.66]) compared with furosemide alone. Coadministration of aliskiren and ISMN was associated with only minor changes in the pharmacokinetic parameters of aliskiren (AUCτ 1.03 [0.90, 1.18]; Cmax 0.94 [0.69, 1.29]) and ISMN (AUCτ 0.88 [0.71, 1.10]; Cmax 0.94 [0.79, 1.13]). Headache and dizziness were the most common adverse events in both studies; dizziness and BP values below normal (SBP <90 and/or DBP <50 mmHg) were more frequent with aliskiren and ISMN coadministration than with either agent alone. Coadministration of aliskiren and ISMN had no clinically relevant effect on either aliskiren or ISMN pharmacokinetics. In conclusion, coadministration of aliskiren and furosemide reduced furosemide exposure and had a minor effect on aliskiren pharmacokinetics. The clinical significance of reduced systemic exposure to furosemide during coadministration of aliskiren is uncertain. 相似文献
79.
Embolic protection devices for carotid artery stenting: better results than stenting without protection? 总被引:11,自引:0,他引:11
Ralf Zahn Bernd Mark Nikolaj Niedermaier Uwe Zeymer Peter Limbourg Thomas Ischinger Klaus Haerten Karl Eugen Hauptmann Enz-Rüdiger von Leitner Wolfgang Kasper Ulrich Tebbe Jochen Senges 《European heart journal》2004,25(17):1550-1558
AIMS: Carotid artery stenting (CAS) for carotid artery stenoses has become an alternative to carotid endarterectomy. However, CAS itself can cause cerebral ischaemic events. Embolic protection devices (PD) promise to reduce the incidence of these events. METHODS AND RESULTS: From July 1996 to March 2003, 1483 patients from 26 hospitals were included in the prospective CAS Registry of the ALKK study group. A PD was used in 668 of 1483 patients (45%). The use of a PD has grown rapidly over the years and reached 100% in 2003. Patients treated with a PD had prior carotid artery dilatation more often (3.5% versus 1%, p < 0.001), a prior myocardial infarction (34% versus 27.4%, p = 0.007) and a history of arterial hypertension (89.9% versus 78.6%, p = 0.007) compared to patients treated without a PD. A thrombus was more often visible in patients treated under distal protection (16.5% versus 8%, p < 0.001). The use of a PD led to a 10-min longer intervention (45 min versus 35 min median, p < 0.001). Patients treated with a PD had a lower rate of ipsilateral stroke (1.7% versus 4.1%, p = 0.007) and a lower rate of all non-fatal strokes and all deaths (2.1% versus 4.9%, p = 0.004) during the hospital stay. This was confirmed by multiple logistic regression analysis (adjusted OR = 0.45, 95% CI: 0.23-0.91, p = 0.026). A similar reduction could be found for symptomatic as well as asymptomatic carotid artery stenoses. CONCLUSION: Since 1996 there has been a steady increase in the use of PDs for CAS, with a 100% use in 2003. The use of a PD may lower the rate of ipsilateral strokes during CAS. 相似文献
80.
Recent technological advances in CT imaging have revolutionized non-invasive imaging of the central airways. It is now possible to image the entire central airways in a few seconds and to create elegant three-dimensional reconstructions of the airways in a few minutes. The fast speed of CT scanning now allows for a dynamic assessment of the central airways, expanding the ability to non-invasively detect functional abnormalities such as tracheobronchomalacia. The purpose of this article is to familiarize clinicians with recent advances in airway imaging. A special emphasis is placed upon advanced CT reconstruction methods and their potential contributions to the evaluation of a variety of airway disorders. 相似文献